Bisphosphonates and hypercalcemiaBONJOUR, J. P; RIZZOLI, R; AMMANN, P et al.Annales d'endocrinologie. 1993, Vol 54, Num 6, pp 399-408, issn 0003-4266Conference Paper

Pharmacokinetic evaluation of pamidronate after oral administration : a study on dose proportionality, absolute bioavailability, and effect of repeated administrationHYLDSTRUP, L; FLESCH, G; HAUFFE, S. A et al.Calcified tissue international. 1993, Vol 53, Num 5, pp 297-300, issn 0171-967XArticle

EPIPHYREAL PLATE SHEAR STRENGTH IN RATS TREATED WITH A DIPHOSPHONATESPENGLER DM; EVANS R; BAYLINK DJ et al.1980; PROC. SOC. EXP. BIOL. MED.; ISSN 0037-9727; USA; DA. 1980; VOL. 165; NO 3; PP. 486-489; BIBL. 19 REF.Article

Effect of topical alendronate treatment on fixation of implants inserted with bone compactionJAKOBSEN, Thomas; KOLD, Søren; BECHTOLD, Joan E et al.Clinical orthopaedics and related research. 2006, Num 444, pp 229-234, issn 0009-921X, 6 p.Article

The determination of alendronate sodium in tablets by inductively coupled plasma (ICP)REED, D. G; MARTIN, G. P; KONIECZNY, J. M et al.Journal of pharmaceutical and biomedical analysis. 1995, Vol 13, Num 8, pp 1055-1058, issn 0731-7085Article

Bisphosphonates: mechanisms of action and clinical useFLEISCH, H.Handbook of experimental pharmacology. 1993, Vol 107, pp 377-417, issn 0171-2004Article

Zoledronate : Efficacy and safetyREID, Ian R.Journal of bone and mineral research (Print). 2006, Vol 21, issn 0884-0431, P83-P87, SUP2Conference Paper

Successful treatment of multicentric reticulohistiocytosis with alendronate: Evidence for a direct effect of bisphosphonate on histiocytesGOTO, Hitoshi; INABA, Masaaki; KOBAYASHI, Keisuke et al.Arthritis and rheumatism. 2003, Vol 48, Num 12, pp 3538-3541, issn 0004-3591, 4 p.Article

Aspects of osseous, peritoneal and renal handling of bisphosphonate during peritoneal dialysis : a methodological studyJOFFE, P; HENRIKSEN, J. H.Scandinavian journal of clinical & laboratory investigation. 1996, Vol 56, Num 4, pp 327-338, issn 0036-5513, 11 p.Article

Effects of ibandronate on bone quality : Preclinical studiesBAUSS, F; DEMPSTER, D. W.Bone (New York, NY). 2007, Vol 40, Num 2, pp 265-273, issn 8756-3282, 9 p.Article

Ulcérations buccales dues aux diphosphonates = Severe oral mucosa ulcerations induced by biphosphonatesLa Revue Prescrire. 2007, Vol 27, Num 283, pp 358-358, issn 0247-7750, 1 p.Article

Alleviation of polyarticular syndrome in multicentric reticulohistiocytosis with intravenous zoledronateMAVRAGANI, C. P; BATZIOU, K; ARONI, K et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 10, pp 1521-1522, issn 0003-4967, 2 p.Article

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis : a pilot studyRINGE, J. D; DORST, A; FABER, H et al.Rheumatology international (Berlin. Print). 2005, Vol 25, Num 4, pp 296-300, issn 0172-8172, 5 p.Article

Severely suppressed bone turnover : A potential complication of alendronate therapyODVINA, Clarita V; ZERWEKH, Joseph E; SUDHAKER RAO, D et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 3, pp 1294-1301, issn 0021-972X, 8 p.Article

Bioequivalence studies on bisphosphonates: The example of alendronateLAINESSE, Audrey; OZALP, Yildiz; HONG WONG et al.Arzneimittel-Forschung. 2004, Vol 54, Num 9A, pp 569-572, issn 0004-4172, 4 p.Article

Bisphosphonates for the treatment of Charcot neuroarthropathyANDERSON, John J; WOELFFER, Kirk E; HOLTZMAN, John J et al.The Journal of foot and ankle surgery. 2004, Vol 43, Num 5, pp 285-289, issn 1067-2516, 5 p.Article

What can nano-chemistry offer to the paint industry ?FELHÖSI, I; TELEGDI, J; PAPP, K et al.Die Makromolekulare Chemie. Macromolecular symposia. 2002, pp 305-315, issn 0258-0322, isbn 3-527-30477-7Conference Paper

Effect of precipitating conditions on the formation of calcium-HEDP precipitatesBROWNING, F. H; FOGLER, H. S.Langmuir. 1996, Vol 12, Num 21, pp 5231-5238, issn 0743-7463Article

Effects of the bisphosphonate, alendronate, on parturition in the ratMINSKER, D. H; MANSON, J. M; PETER, C. P et al.Toxicology and applied pharmacology. 1993, Vol 121, Num 2, pp 217-223, issn 0041-008XArticle

Diez casos de osteonecrosis mandíbular (ONM) asociada a bisfosfonatos = Ten cases of osteonecrosis of the jaw related with biphosphonatesFERREIRO, S. Varela; OZORES, P. Palacios; SALGADO BOQUETE, L et al.Oncología (Barcelona). 2007, Vol 30, Num 4, pp 13-21, issn 0378-4835, 9 p.Article

Ibandronate : Un nouveau bisphosphonate par voie orale = Ibandronate : a new oral bisphosphonateThe Medical letter on drugs and therapeutics (Edition française). 2005, Vol 27, Num 11, pp 55-56, issn 0253-8512, 2 p.Article

Goals of treatment for Paget's disease of boneSIRIS, E. S.Journal of bone and mineral research (Print). 1999, Vol 14, pp 49-52, issn 0884-0431, SUP2Conference Paper

Les métastases osseuses : Pathogenèse et traitement par les bisphosphonates. Discussion = Bone metastasis : pathophysiology and diphosphonate treatmentBODY, J. J; GOLDMAN, M; VANDERHOEFT, P et al.Bulletin et mémoires de l'Académie Royale de Médecine de Belgique. 1997, Vol 152, Num 3, pp 169-176, issn 0377-8231Article

Metabolism of the bisphosphonate ester U-91502 in ratsSLATTER, J. G; FEENSTRA, K. L; HAUER, M. J et al.Drug metabolism and disposition. 1996, Vol 24, Num 1, pp 65-73, issn 0090-9556Article

Human neutrophil priming: chemiluminescence modified by hydroxyapatite and three bisphosphonates in vitroHYVÖNEN, P. M; KOWOLIK, M.J.Journal of clinical & laboratory immunology. 1993, Vol 40, Num 2, pp 69-76, issn 0141-2760Article